» Articles » PMID: 36892308

The Cystic Fibrosis Upper and Lower Airway Metagenome

Abstract

The microbial metagenome in cystic fibrosis (CF) airways was investigated by whole-genome shotgun sequencing of total DNA isolated from nasal lavage samples, oropharyngeal swabs, and induced sputum samples collected from 65 individuals with CF aged 7 to 50 years. Each patient harbored a personalized microbial metagenome unique in microbial load and composition, the exception being monocultures of the most common CF pathogens Staphylococcus aureus and Pseudomonas aeruginosa from patients with advanced lung disease. The sampling of the upper airways by nasal lavage uncovered the fungus Malassezia restricta and the bacterium Staphylococcus epidermidis as prominent species. Healthy and CF donors harbored qualitatively and quantitatively different spectra of commensal bacteria in their sputa, even in the absence of any typical CF pathogen. If P. aeruginosa, S. aureus, or Stenotrophomonas maltophilia belonged to the trio of the most abundant species in the CF sputum metagenome, common inhabitants of the respiratory tract of healthy subjects, i.e., Eubacterium sulci, Fusobacterium periodonticum, and Neisseria subflava, were present only in low numbers or not detectable. Random forest analysis identified the numerical ecological parameters of the bacterial community, such as Shannon and Simpson diversity, as the key parameters that globally distinguish sputum samples from CF and healthy donors. Cystic fibrosis (CF) is the most common life-limiting monogenetic disease in European populations and is caused by mutations in the gene. Chronic airway infections with opportunistic pathogens are the major morbidity that determines prognosis and quality of life in most people with CF. We examined the composition of the microbial communities of the oral cavity and upper and lower airways in CF patients across all age groups. From early on, the spectrum of commensals is different in health and CF. Later on, when the common CF pathogens take up residence in the lungs, we observed differential modes of depletion of the commensal microbiota in the presence of S. aureus, P. aeruginosa, S. maltophilia, or combinations thereof. It remains to be seen whether the implementation of lifelong CFTR (cystic fibrosis transmembrane conductance regulator) modulation will change the temporal evolution of the CF airway metagenome.

Citing Articles

Effects of Therapeutic Antibiotic Exposure on the Oropharyngeal and Fecal Microbiota in Infants With Cystic Fibrosis.

Hayden H, Nelson M, Ross S, Verster A, Bouzek D, Eng A Pediatr Pulmonol. 2025; 60(3):e71024.

PMID: 40042126 PMC: 11881217. DOI: 10.1002/ppul.71024.


Airway Mycobiota-Microbiota During Pulmonary Exacerbation of Cystic Fibrosis Patients: A Culture and Targeted Sequencing Study.

Angebault C, Vandenborght L, Bassinet L, Wizla N, Ferroni A, Dessein R Mycoses. 2025; 68(1):e70024.

PMID: 39816006 PMC: 11736540. DOI: 10.1111/myc.70024.


Human CFTR deficient iPSC-macrophages reveal impaired functional and transcriptomic response upon infection.

Rodriguez Gonzalez C, Basilio-Queiros D, Neehus A, Merkert S, Tschritter D, Unal S Front Immunol. 2024; 15:1397886.

PMID: 39606224 PMC: 11601075. DOI: 10.3389/fimmu.2024.1397886.


Metagenomics Applied to the Respiratory Mycobiome in Cystic Fibrosis.

Angebault C, Botterel F Mycopathologia. 2024; 189(5):82.

PMID: 39264513 PMC: 11392981. DOI: 10.1007/s11046-024-00887-6.


in chronic lung disease: untangling the dysregulated host immune response.

Nickerson R, Thornton C, Johnston B, Lee A, Cheng Z Front Immunol. 2024; 15:1405376.

PMID: 39015565 PMC: 11250099. DOI: 10.3389/fimmu.2024.1405376.


References
1.
Mainz J, Gerber A, Arnold C, Baumann J, Baumann I, Koitschev A . [Rhinosinusitis in cystic fibrosis]. HNO. 2015; 63(11):809-20. DOI: 10.1007/s00106-015-0069-7. View

2.
Cuthbertson L, Walker A, Oliver A, Rogers G, Rivett D, Hampton T . Lung function and microbiota diversity in cystic fibrosis. Microbiome. 2020; 8(1):45. PMC: 7114784. DOI: 10.1186/s40168-020-00810-3. View

3.
Bevivino A, Bacci G, Drevinek P, Nelson M, Hoffman L, Mengoni A . Deciphering the Ecology of Cystic Fibrosis Bacterial Communities: Towards Systems-Level Integration. Trends Mol Med. 2019; 25(12):1110-1122. DOI: 10.1016/j.molmed.2019.07.008. View

4.
Mainz J, Naehrlich L, Schien M, Kading M, Schiller I, Mayr S . Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis. Thorax. 2009; 64(6):535-40. DOI: 10.1136/thx.2008.104711. View

5.
Mika M, Korten I, Qi W, Regamey N, Frey U, Casaulta C . The nasal microbiota in infants with cystic fibrosis in the first year of life: a prospective cohort study. Lancet Respir Med. 2016; 4(8):627-635. DOI: 10.1016/S2213-2600(16)30081-9. View